# Insulin Glargine in Type 2 Diabetes

> **NCT00268645** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 534 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Glargine

## Key facts

- **NCT ID:** NCT00268645
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 534 (—)
- **Last updated:** 2011-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00268645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00268645, "Insulin Glargine in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00268645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*